Adar Poonawalla, executive director and chief executive officer of the world’s largest vaccine producer Serum Institute of India Ltd and scion of the $5.2 billion farms-to-pharma Cyrus Poonawalla Group, is committed to taking forward the strong healthcare legacy that his father (chairman Cyrus Poonawala) created over a period of five decades. “We have no intention to sell our company as it doesn’t make sense to sell a long-established business, which is our core strength, and get into something new that we don’t have any expertise in,” he said.
Edited excerpts from an interview.